The US Food and Drug Administration’s anesthesiology and respiratory therapy devices advisory committee agreed that pulse oximeters with decreased accuracy on patients with dark skin is a problem that comes with clinical implications.
Pulse oximeters measure spO2, which is a percentage of oxygenated hemoglobin to deoxygenated hemoglobin.